Event Detail
ExL Pharma's 5th Annual Pharmaceutical Pricing & Reimbursement Conference
July 16 - 17, 2009
- Bridgewater NJ UNITED STATES
ExL Pharma
The Obama Administration has made Healthcare reform a major priority with a special focus on pricing and reimbursement in particular. Mandatory changes in how prices are determined for both private and government funded coverage are immanent, and significant additional factors will have to be considered. Mainly, that full-access to different reimbursement avenues will not be a given. Continuing a history of strong participation, the 5th Annual Pharmaceutical Pricing & Reimbursement conference will once again provide a look into how pharmaceutical companies are adjusting their pricing strategies based on the current economic climate and the rapidly changing government landscape. Topics Covered: * Healthcare in the United States Under the Obama Administration and Pricing Implications * Rebate Care and Part D - Revenue and Estimated Rebate Liability Forecasting * Shaping Early Discovery Strategy to Develop Drugs that have Greater Reimbursement Success * Understanding how a Product is Sold and Dispensed to Determine Pricing and Reimbursement * A Global Context for Comparative Effectiveness, Implications to Product Development and Successful Commercialization * Key Litigation and Legislation that will Affect how the Industry Determines Pricing * The Intersection of REMS in Driving Reibursement & Access Strategy * New ISD-10 Coding System * European Health Economic Evaluations: Adoptable Practices * Optimizing your Strategy Over the Product Life Cycle * Examining the Distinction between Evidence Requirements in the U.S. It's a crucial time for reform and I urge you to join us at this timely event!